Stéphanie Héon

1.1k total citations
10 papers, 444 citations indexed

About

Stéphanie Héon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Stéphanie Héon has authored 10 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in Stéphanie Héon's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (4 papers). Stéphanie Héon is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Lung Cancer Research Studies (4 papers). Stéphanie Héon collaborates with scholars based in United States and Canada. Stéphanie Héon's co-authors include Bruce E. Johnson, David M. Jackman, Daniel B. Costa, Beow Y. Yeap, Michael S. Rabin, Mohit Butaney, Neal I. Lindeman, Victoria A. Joshi, Lecia V. Sequist and Lorraine E. Chalifour and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Stéphanie Héon

10 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stéphanie Héon United States	7	395	360	73	29	23	10	444
Yasuhiro Hiyoshi Japan	11	191 0.5×	257 0.7×	53 0.7×	19 0.7×	6 0.3×	28	329
Daniela Iacono Italy	9	266 0.7×	228 0.6×	141 1.9×	64 2.2×	7 0.3×	19	372
Samuel Martel Belgium	10	106 0.3×	221 0.6×	63 0.9×	64 2.2×	34 1.5×	22	289
Maciej Bryl Poland	9	117 0.3×	176 0.5×	72 1.0×	49 1.7×	6 0.3×	32	273
Masayoshi Miyawaki Japan	5	226 0.6×	180 0.5×	121 1.7×	44 1.5×	9 0.4×	7	261
Hanako Kuhara Japan	10	170 0.4×	117 0.3×	98 1.3×	33 1.1×	18 0.8×	24	271
Beili Gao China	10	106 0.3×	135 0.4×	122 1.7×	42 1.4×	17 0.7×	24	278
Ekaterine Alexandris United States	9	148 0.4×	158 0.4×	58 0.8×	26 0.9×	7 0.3×	16	226
Shailesh Bondarde India	8	74 0.2×	152 0.4×	71 1.0×	56 1.9×	6 0.3×	25	237
Lara Iglesias Docampo Spain	7	123 0.3×	115 0.3×	54 0.7×	24 0.8×	7 0.3×	13	166

Countries citing papers authored by Stéphanie Héon

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Héon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Héon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Héon more than expected).

Fields of papers citing papers by Stéphanie Héon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Héon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Héon. The network helps show where Stéphanie Héon may publish in the future.

Co-authorship network of co-authors of Stéphanie Héon

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Héon. A scholar is included among the top collaborators of Stéphanie Héon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Héon. Stéphanie Héon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Héon, Stéphanie & Bruce E. Johnson. (2012). Adjuvant chemotherapy for surgically resected non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 144(3). S39–S42. 36 indexed citations

Gill, Ritu R., Stéphanie Héon, Beow Y. Yeap, et al.. (2012). Genomic profiling of non-small cell lung cancer (NSCLC) for personalized targeted therapy using CT-guided transthoracic needle biopsy (TTNB).. Journal of Clinical Oncology. 30(15_suppl). 10592–10592. 3 indexed citations

Nishino, Mizuki, Stéphanie Héon, Suzanne E. Dahlberg, et al.. (2012). Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors.. Journal of Clinical Oncology. 30(15_suppl). 7553–7553. 1 indexed citations

Héon, Stéphanie, Mizuki Nishino, Sarah B. Goldberg, et al.. (2012). Response to EGFR tyrosine kinase inhibitor (TKI) retreatment after a drug-free interval in EGFR-mutant advanced non-small cell lung cancer (NSCLC) with acquired resistance.. Journal of Clinical Oncology. 30(15_suppl). 7525–7525. 13 indexed citations

Héon, Stéphanie, Beow Y. Yeap, Neal I. Lindeman, et al.. (2012). The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with EGFR Mutations. Clinical Cancer Research. 18(16). 4406–4414. 144 indexed citations

Oxnard, Geoffrey R., Peter Lo, David M. Jackman, et al.. (2012). Delay of chemotherapy through use of post-progression erlotinib in patients with EGFR-mutant lung cancer.. Journal of Clinical Oncology. 30(15_suppl). 7547–7547. 32 indexed citations

Héon, Stéphanie, Beow Y. Yeap, Daniel B. Costa, et al.. (2010). Development of Central Nervous System Metastases in Patients with Advanced Non–Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib. Clinical Cancer Research. 16(23). 5873–5882. 176 indexed citations

Mwale, F., Caroline N. Demers, John Antoniou, et al.. (2005). Amifostine and Dexrazoxane Enhance the Rapid Loss of Bone Mass and Further Deterioration of Vertebrae Architecture in Female Rats. Calcified Tissue International. 77(3). 175–179. 4 indexed citations

Mwale, F., John Antoniou, Stéphanie Héon, et al.. (2004). Gender-Dependent Reductions in Vertebrae Length, Bone Mineral Density and Content by Doxorubicin Are Not Reduced by Dexrazoxane in Young Rats: Effect on Growth Plate and Intervertebral Discs. Calcified Tissue International. 76(3). 214–221. 9 indexed citations

10.

Héon, Stéphanie, Martin Bernier, Nicolas Servant, et al.. (2003). Dexrazoxane does not protect against doxorubicin-induced damage in young rats. American Journal of Physiology-Heart and Circulatory Physiology. 285(2). H499–H506. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact